Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter TrialYair Lotan, Stephen A. Boorjian, Leah Davis et al.|The Journal of Urology|2019Cited by 27
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy Downs, Edward M. Messing|Cancer Prevention Research|2024Cited by 2